{
    "id": "61f593f8882a024a1000000f",
    "question": "Is there an association between pyostomatitis vegetans and Crohn's disease?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the provided documents to see if there is any association between pyostomatitis vegetans and Crohn's disease. Pyostomatitis vegetans is mentioned in Document [0] as a dermatologic manifestation of inflammatory bowel disease, which includes Crohn's disease. According to Document [0], pyoderma vegetans, which is similar to pyostomatitis vegetans, occurs in intertriginous areas and is associated with inflammatory bowel disease. This suggests a possible connection between pyostomatitis vegetans and Crohn's disease. However, we need to look for a direct association between the two conditions. Document [0] does not explicitly state a direct association between pyostomatitis vegetans and Crohn's disease. We should also consider the definition of pyostomatitis vegetans in Document [0], which is not explicitly linked to Crohn's disease. However, Document [0] does mention that pyoderma vegetans, a similar condition, is associated with inflammatory bowel disease, which includes Crohn's disease. In addition, Document [1] mentions that Crohn's disease can have extraintestinal manifestations, including skin manifestations. Therefore, it is possible that pyostomatitis vegetans could be an extraintestinal manifestation of Crohn's disease. However, without a direct statement in Document [0] explicitly linking pyostomatitis vegetans to Crohn's disease, we cannot make a definitive conclusion. Nevertheless, based on the information provided, we can infer a possible association between pyostomatitis vegetans and Crohn's disease due to the association of pyoderma vegetans with inflammatory bowel disease, which includes Crohn's disease.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_22931",
            "title": "InternalMed_Harrison",
            "content": "1958 Other dermatologic manifestations include pyoderma vegetans, which occurs in intertriginous areas; pyostomatitis vegetans, which involves the mucous membranes; Sweet syndrome, a neutrophilic dermatosis; and metastatic CD, a rare disorder defined by cutaneous granuloma formation. Psoriasis affects 5\u201310% of patients with IBD and is unrelated to bowel activity consistent with the potential shared immunogenetic basis of these diseases. Perianal skin tags are found in 75\u201380% of patients with CD, especially those with colon involvement. Oral mucosal lesions, seen often in CD and rarely in UC, include aphthous stomatitis and \u201ccobblestone\u201d lesions of the buccal mucosa."
        },
        {
            "id": "Surgery_Schwartz_8154",
            "title": "Surgery_Schwartz",
            "content": "among monozygotic twins is as high as 67%; how-ever, Crohn\u2019s disease is not associated with simple Mendelian inheritance patterns. Although there is a tendency within fami-lies for either ulcerative colitis or Crohn\u2019s disease to be present exclusively, mixed kindreds also occur, suggesting the presence of some shared genetic traits as a basis for both diseases.Higher socioeconomic status is associated with an increased risk of Crohn\u2019s disease. Most studies have found breastfeeding to be protective against the development of Crohn\u2019s disease. Crohn\u2019s disease is more prevalent among smokers. Furthermore, smoking is associated with the increased risk for both the need for surgery and the risk of relapse after surgery for Crohn\u2019s disease.PathophysiologyCrohn\u2019s disease is characterized by sustained inflammation. Whether this inflammation represents an appropriate response to a yet unrecognized pathogen or an inappropriate response to a normally innocuous stimulus is unknown. Various"
        },
        {
            "id": "Immunology_Janeway_3843",
            "title": "Immunology_Janeway",
            "content": "In humans, genetic susceptibility to autoimmune disorders has been recently assessed by large-scale genome-wide association studies (GWASs), which look for a correlation between disease frequency and genetic variants (typically single-nucleotide polymorphisms, or SNPs). Such studies typically involve thousands of patients with a given autoimmune disease diagnosis and Fig. 15.34 Manhattan plot depicting risk alleles from genome-wide association studies (GWASs) of Crohn\u2019s disease. The plot highlights selected gene loci identified by analyses of single nuclear polymorphisms (SNPs) with highly significant disease associations in patients with Crohn\u2019s disease compared with healthy controls (see also Section 15\u201123). The height of the peaks reflects the statistical significance of the association. The dotted line indicates the threshold for significant associations (5 \u00d7 10\u201308). Figure courtesy of John Rioux and Ben Weaver."
        },
        {
            "id": "Surgery_Schwartz_8155",
            "title": "Surgery_Schwartz",
            "content": "sustained inflammation. Whether this inflammation represents an appropriate response to a yet unrecognized pathogen or an inappropriate response to a normally innocuous stimulus is unknown. Various hypotheses on the roles of environmental and genetic factors in the patho-genesis of Crohn\u2019s disease have been proposed. Many infec-tious agents have been suggested to be the causative organism of Crohn\u2019s disease; however, there has been no conclusive evidence to confirm any. Studies using animal models suggest that in a genetically susceptible host, a nonpathogenic gut microbiome is sufficient to induce a chronic inflammatory response resembling Brunicardi_Ch28_p1219-p1258.indd 123523/02/19 2:24 PM 1236SPECIFIC CONSIDERATIONSPART IIthat associated with Crohn\u2019s disease. In these models, the sus-tained intestinal inflammation is the result of either abnormal epithelial barrier function or immune dysregulation. A full dis-cussion of the role of gut immune system and microbiome in the"
        },
        {
            "id": "Pathology_Robbins_3767",
            "title": "Pathology_Robbins",
            "content": "Both Crohn disease and ulcerative colitis frequently present during adolescence or in young adults, although some studies suggest a second, smaller peak in the incidence of both diseases after the fifth decade. In Western http://ebooksmedicine.net Table 15.5 Features of Crohn Disease and Ulcerative Colitis Feature Crohn Disease Ulcerative Colitis submucosaPseudopolypsModerateMarkedUlcersDeep, knifelikeSuperficial, broad-basedLymphoid reactionMarkedModerateFibrosisMarkedMild to noneSerositisMarkedNoGranulomasYes (\u223c35%)NoFistulas/sinusesYesNo Perianal fistulaYes (in colonic Nodisease)Fat/vitamin YesNomalabsorptionMalignant potentialWith colonic YesinvolvementRecurrence after CommonNosurgeryToxic megacolonNoYesNOTE: Not all features may be present in a single case."
        },
        {
            "id": "Surgery_Schwartz_8443",
            "title": "Surgery_Schwartz",
            "content": "in the interferon-gamma\u2013mediated clearance of intracellular pathogens. Variants in this gene are associated with a higher incidence of ileocolic resections in Crohn\u2019s disease patients.42-44Patients with IBD appear to have a chronic immune dys-regulation, which may lead to an interplay with gut microbes which are also present in non-IBD patients, but which elicit pathologic immune responses in the IBD population leading to chronic, idiopathic inflammation of the alimentary tract. Bacteria such as Mycobacterium paratuberculosis and Liste-ria monocytogenes, as well as viruses such as paramyxovirus and measles virus, have been suggested as having a role in the development of Crohn\u2019s disease. With the decreased cost of sequencing and with the expansion of reference databases for identification of organisms, microbiome studies have been applied to the study of IBD patients, both to learn about the pathogenesis of IBD as well as for disease prognostication. Recent studies have identified an"
        },
        {
            "id": "Surgery_Schwartz_8162",
            "title": "Surgery_Schwartz",
            "content": "is a disease of the colon, it can be associated with inflammatory changes in the distal ileum (backwash ileitis).Clinical PresentationThe most common symptoms of Crohn\u2019s disease are abdominal pain, diarrhea, and weight loss. However, the clinical features are highly variable among individual patients and depend on which segment(s) of the gastrointestinal tract is (are) predomi-nantly affected, the intensity of inflammation, and the presence or absence of specific complications. In fact, some patients with Crohn\u2019s disease may have been initially misdiagnosed as having irritable bowel syndrome or celiac disease.Patients can be classified by their predominant clinical manifestation as having primarily (a) fibrostenotic disease, (b) fistulizing disease, and (c) aggressive inflammatory disease. There is substantial overlap among these disease patterns in individual patients, however. The onset of symptoms is insidious, and once present, their severity follows a waxing and waning course."
        },
        {
            "id": "Surgery_Schwartz_8164",
            "title": "Surgery_Schwartz",
            "content": "disease. One Brunicardi_Ch28_p1219-p1258.indd 123623/02/19 2:24 PM 1237SMALL INTESTINECHAPTER 28fourth of those affected will have more than one manifestation. Many of these complications can be seen with both Crohn\u2019s disease and ulcerative colitis, although they are more prevalent among patients with Crohn\u2019s disease. The most common extraintestinal manifestations are listed in Table 28-7. The clinical severity of some of these manifestations, such as erythema nodosum and peripheral arthritis, are correlated with the severity of intestinal inflammation. The severity of other manifestations, such as pyoderma gangrenosum and ankylosing spondylitis, bear no apparent relationship to the severity of intestinal inflammation.DiagnosisThe diagnosis is usually established with endoscopic findings in a patient with a compatible clinical history. The diagnosis should be considered in those presenting with acute or chronic abdominal pain, especially when localized to the right lower quadrant,"
        },
        {
            "id": "Surgery_Schwartz_8444",
            "title": "Surgery_Schwartz",
            "content": "of organisms, microbiome studies have been applied to the study of IBD patients, both to learn about the pathogenesis of IBD as well as for disease prognostication. Recent studies have identified an abundance of Serratia marc-escens, E coli, and Candida tropicalis in the guts of patients with Crohn\u2019s disease. In a study of 543 stool samples, patients with ulcerative colitis and primary sclerosing cholangitis (PSC) demonstrated a distinct bacterial community structure, with an enrichment of bacteria belonging to the Veillonella genus, which is associated with several diseases characterized by inflammation and fibrosis.45-49A defect in the gut mucosal barrier, which increases exposure to intestinal microbes as well as proinflammatory substances, is a potential etiologic factor related to immune dys-regulation. An autoimmune mechanism has also been postulated. Although there is no clear evidence linking an immunologic disorder to inflammatory bowel disease, the similarity of many of the"
        },
        {
            "id": "Immunology_Janeway_3844",
            "title": "Immunology_Janeway",
            "content": "healthy controls in order to identify highly significant associations. Example results from GWASs that identify candidate genes linked to Crohn's disease are shown in the \u2018Manhattan\u2019 plot in Fig. 15.34. These plots are so named because they resemble a profile view of skyscrapers in the Manhattan skyline. Here, genomic coordinates are located on the x-axis, with the negative logarithm of the P-value of the association being given on the y-axis, and each assayed SNP is represented by a dot. Thus, the variants with the greatest disease association are the \u2018tallest skyscrapers\u2019 on the plot. Using this approach, hundreds of significant variants have been identified for multiple autoimmune diseases, suggesting that genetic susceptibility to autoimmune disease in humans may be due to a combination of susceptibility alleles at multiple loci."
        },
        {
            "id": "Surgery_Schwartz_8439",
            "title": "Surgery_Schwartz",
            "content": "lower in Asia, Africa, and South America, and among the nonwhite population in the United States. Ulcerative coli-tis incidence peaks during the third decade of life and again in the seventh decade of life. The incidence of Crohn\u2019s disease is slightly lower, 1 to 5 people per 100,000. Crohn\u2019s disease also affects Northern European and Caucasian populations dispro-portionately. Crohn\u2019s disease has a similar bimodal incidence, with most cases occurring between ages 15 to 30 years and ages 60 to 70 years.38 In 15% of patients with inflammatory bowel disease, differentiation between ulcerative colitis and Crohn\u2019s colitis is impossible; these patients are classified as having indeterminate colitis.Etiology. Inflammatory bowel disease is a multifactorial con-dition that includes environmental, genetic, and immune causal elements; the variation in disease distributions and severity, as well as the differential responses to medical therapy, reflect a complex pathophysiology that is not"
        },
        {
            "id": "Pathology_Robbins_3776",
            "title": "Pathology_Robbins",
            "content": "Epithelial defects. A variety of epithelial defects have been described in Crohn disease, ulcerative colitis, or both. For example, defects in intestinal epithelial tight junction barrier function occur in patients with Crohn disease and a subset of their healthy first-degree relatives. This barrier dysfunction cosegregates with specific disease-associated NOD2 polymorphisms, and experimental models demonstrate that barrier dysfunction can activate innate and adaptive mucosal immunity and sensitize subjects to disease. Interestingly, the Paneth cell granules, which contain anti-microbial peptides that can affect composition of the luminal microbiota, are abnormal in patients with Crohn disease carrying ATG16L1 mutations, thus providing one potential mechanism in which a defective feedback loop between the epithelium and microbiota could contribute to disease pathogenesis."
        },
        {
            "id": "First_Aid_Step2_1233",
            "title": "First_Aid_Step2",
            "content": "A 25-year-old Jewish man presents with pain and watery diarrhea after meals. Exam shows fistulas between the bowel and skin and nodular lesions on his tibias. In\ufb02ammatory disease of the colon with \u2191 risk of colon cancer. Extraintestinal manifestations of IBD. Medical treatment for IBD. Difference between Mallory-Weiss and Boerhaave tears. Charcot\u2019s triad. Reynolds\u2019 pentad. Medical treatment for hepatic encephalopathy. HIDA scan. Fat, female, fertile, forty, \ufb02 atulent. Murphy\u2019s sign, seen in acute cholecystitis. Hernia. Adhesions. S. aureus E. coli O157:H7 Bacillus cereus Salmonella Vibrio, HAV Isospora, Cryptosporidium, Mycobacterium avium complex Crohn\u2019s disease. Ulcerative colitis (greater risk than Crohn\u2019s). Uveitis, ankylosing spondylitis, pyoderma gangrenosum, erythema nodosum, 1\u00b0 sclerosing cholangitis. 5-ASA agents and steroids during acute exacerbations. Mallory-Weiss\u2014superficial tear in the esophageal mucosa; Boerhaave\u2014full-thickness esophageal rupture."
        },
        {
            "id": "Pathology_Robbins_3771",
            "title": "Pathology_Robbins",
            "content": "Molecular linkage analyses of affected families have identified NOD2 (nucleotide oligomerization binding domain 2) as a susceptibility gene in Crohn disease. NOD2 encodes a protein that binds to intracellular bacterial peptidoglycans and subsequently activates NF-\u03baB. Some studies suggest that the disease-associated form of NOD-2 is ineffective at defending against intestinal bacteria. The result is that bacteria are able to enter through the epithelium into the wall of the intestine, where they trigger inflammatory reactions. It should, however, be recognized that disease develops in less than 10% of individuals carrying specific NOD2 polymorphisms, and these polymorphisms are uncommon in African and Asian patients with Crohn disease."
        },
        {
            "id": "Surgery_Schwartz_8158",
            "title": "Surgery_Schwartz",
            "content": "may increase the risk of developing Crohn\u2019s disease. A meta-analysis has, however, suggested that the observed increased risk of Crohn\u2019s disease in the first few years after an appendectomy may in fact reflect diagnostic dif-ficulty in a group of patients with incipient Crohn\u2019s.39Although the pathological hallmark of Crohn\u2019s disease is focal, transmural inflammation of the intestine, a spectrum of pathological lesions can be present. The earliest lesion characteristic of Crohn\u2019s disease is the aphthous ulcer. These superficial ulcers are up to 3 mm in diameter and are surrounded by a halo of erythema. In the small intestine, aphthous ulcers typically arise over lymphoid aggregates. Granulomas are highly characteristic of Crohn\u2019s disease and are reported to be present in up to 70% of intestinal specimens obtained during surgical resection. These granulomas are noncaseating and can be found in both areas of active disease and apparently normal intestine, in any layer of the bowel wall,"
        },
        {
            "id": "Pathology_Robbins_5251",
            "title": "Pathology_Robbins",
            "content": "http://ebooksmedicine.net Fig. 24.11 Pemphigusfoliaceus.(A)Atypicalblister,whichismoresuperfi-cialthanthoseseeninpemphigusvulgaris.(B)Microscopicappearanceofacharacteristicsubcornealblister. Dermatitis herpetiformis is an autoimmune blistering disorder associated with gluten sensitivity that is characterized by extremely pruritic grouped vesicles and papules. The disease affects predominantly males, often in the third and fourth decades of life. Up to 80% of cases are associated with celiac disease; conversely, only a small fraction of patients with celiac disease develop dermatitis herpetiformis. Like celiac disease, dermatitis herpetiformis responds to a gluten-free diet."
        },
        {
            "id": "InternalMed_Harrison_22844",
            "title": "InternalMed_Harrison",
            "content": "(Adapted from A Kaser et al: Annu Rev Immunol 28:573, 2010.) and Hispanic CD patients, but not UC patients, had a lower prevalence of family history of IBD than their white counterparts. There are few data on all aspects of disease in Hispanics, in the incidence and prevalence of IBD in African Americans, and in Asians with IBD outside Asia. These ethnic variations implicate the importance of different genetic and/or environmental factors in the pathogenesis of this disorder. Environment Undiagnosedinfections?Early onset Genetics"
        },
        {
            "id": "Surgery_Schwartz_8153",
            "title": "Surgery_Schwartz",
            "content": "of developing Crohn\u2019s disease than members of other popu-lations living in the same location.Most studies suggest that Crohn\u2019s disease is slightly more prevalent in females than in males. The mean age at which patients are diagnosed with Crohn\u2019s disease falls in the third decade of life years, with a second smaller peak in the sixth decade of life, giv-ing it a bimodal distribution. The age at diagnosis can, however, range from early childhood through the entire lifespan.Both genetic and environmental factors appear to influ-ence the risk for developing Crohn\u2019s disease. The relative risk among first-degree relatives of patients with Crohn\u2019s disease is 14 to 15 times higher than that of the general population, with about 20% of patients reporting a family history. The concor-dance rate among monozygotic twins is as high as 67%; how-ever, Crohn\u2019s disease is not associated with simple Mendelian inheritance patterns. Although there is a tendency within fami-lies for either ulcerative"
        },
        {
            "id": "Surgery_Schwartz_8758",
            "title": "Surgery_Schwartz",
            "content": "of old-age colitis in the Dutch inflammatory bowel dis-ease population. World J Gastroenterol. 2008;14:3183-3187. 39. Bonen DK, Cho JH. The genetics of inflammatory bowel dis-ease. Gastroenterology. 2003;124:521-536. 40. Yamamoto-Furusho JK. Genetic factors associated with the development of inflammatory bowel disease. World J Gastro-enterol. 2007;13:5594-5597. 41. Halme L, Paavola-Sakki P, Turunen U, et al. Family and twin studies in inflammatory bowel disease. World J Gastroenterol. 2006;12:3668-3672. 42. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature. 2001;411:599-603. 43. Sehgal R, Berg A, Hegarty JP, et al. NOD2/CARD15 muta-tions correlate with severe pouchitis after ileal pouch-anal anastomosis. Dis Colon Rectum. 2010;53(11):1487-1494. 44. Sehgal R, Berg A, Polinski JI, et al. Mutations in IRGM are associated with more frequent need for surgery in patients with ileocolonic Crohn\u2019s disease."
        },
        {
            "id": "Obstentrics_Williams_7450",
            "title": "Obstentrics_Williams",
            "content": "Two presumably noninfectious forms of intestinal inlammation are ulcerative colitis and Crohn disease. Diferentiation between these is important because treatment difers. That said, they both share common features, and sometimes are indistinguishable if Crohn disease involves the colon. he salient clinical and laboratory features shown in Table 54-5 permit a reasonably confident diagnostic diferentiation in most cases. he etiopathogenesis is enigmatic in both, but a genetic predisposition is suspected. Inlammation is thought to result from dysregulated mucosal immune function in response to commensal microbiota, with or without an autoimmune component (Friedman, 2015). TABLE 54-5. Some Shared and Diferentiating Characteristics of Inflammatory Bowel Disease Hereditary More than 100 disease-associated genetic loci-a third shared; Jewish predominance; familial in 5-10% of cases; Turner syndrome; immune dysregulation"
        },
        {
            "id": "Surgery_Schwartz_8448",
            "title": "Surgery_Schwartz",
            "content": "noncaseating granulomas are characteristic pathologic findings. Chronic inflammation may ultimately result in fibrosis, strictures, and fistulas in either the colon or small intestine. The endoscopic appearance of Crohn\u2019s colitis is characterized by deep serpiginous ulcers and a \u201ccob-blestone\u201d appearance. Skip lesions and rectal sparing are com-mon. Symptoms of Crohn\u2019s disease depend on the severity of inflammation and/or fibrosis and the location of inflammation in the gastrointestinal tract. Acute inflammation may produce diarrhea, crampy abdominal pain, and fever. Strictures may pro-duce symptoms of obstruction. Weight loss is common, both because of obstruction and from protein loss. Perianal Crohn\u2019s disease may present with pain, swelling, and drainage from fis-tulas or abscesses. Physical findings are also related to the site and severity of disease.In 15% of patients with colitis from inflammatory bowel disease, differentiation of ulcerative colitis from Crohn\u2019s colitis is"
        },
        {
            "id": "Surgery_Schwartz_8759",
            "title": "Surgery_Schwartz",
            "content": "Dis Colon Rectum. 2010;53(11):1487-1494. 44. Sehgal R, Berg A, Polinski JI, et al. Mutations in IRGM are associated with more frequent need for surgery in patients with ileocolonic Crohn\u2019s disease. Dis Colon Rectum. 2012;55(2):115-121. 45. Hoarau G, Mukherjee PK, Gower-Rousseau C, et al. Bac-teriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn\u2019s disease. mBio. 2016;7(5). pii: e01250-16. 46. Strisciuglio C, Duijvestein M, Verhaar AP, et al. Impaired autophagy leads to abnormal dendritic cell-epithelial cell interactions. J Crohns Colitis. 2013;7(7):534-541. 47. Brinar M, Vermeire S, Cleynen I, et al. Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn\u2019s disease patients. J Crohns Colitis. 2012;6(1):43-50. 48. Strisciuglio C, Duijvestein M, Verhaar AP, et al. Impaired autophagy leads to abnormal dendritic cell-epithelial cell interactions. J Crohns Colitis. 2013;7(7):534-541. 49. Brinar M, Vermeire S,"
        },
        {
            "id": "Pathology_Robbins_3766",
            "title": "Pathology_Robbins",
            "content": "Inflammatory bowel disease (IBD) is a chronic condition resulting from complex interactions between intestinal microbiota and host immunity in genetically predisposed individuals resulting an inappropriate mucosal immune activation. IBD encompasses two entities, Crohn disease and ulcerative colitis. The distinction between ulcerative colitis and Crohn disease is based, in large part, on the distribution of affected sites and the morphologic expression of disease at those sites ( Fig. 15.26 Table 15.5 ). Ulcerative colitis is limited to the colon and rectum and extends only into the mucosa and submucosa. By contrast, Crohn disease, also referred to as regional enteritis (because of frequent ileal involvement), may involve any area of the gastrointestinal tract and is frequently transmural."
        },
        {
            "id": "Pharmacology_Katzung_6945",
            "title": "Pharmacology_Katzung",
            "content": "FIGURE 62\u20137 Therapeutic pyramid approach to inflammatory bowel diseases. Treatment choice is predicated on both the severity of the illness and the responsiveness to therapy. Agents at the bottom of the pyramid are less efficacious but carry a lower risk of serious adverse effects. Drugs may be used alone or in various combinations. Patients with mild disease may be treated with 5-aminosalicylates (with ulcerative colitis or Crohn\u2019s colitis), topical corticosteroids (ulcerative colitis), antibiotics (Crohn\u2019s colitis or Crohn\u2019s perianal disease), or budesonide (Crohn\u2019s ileitis). Patients with moderate disease or patients who fail initial therapy for mild disease may be treated with oral corticosteroids to promote disease remission; immunomodulators (azathioprine, mercaptopurine, methotrexate) to promote or maintain disease remission; or anti-TNF antibodies. Patients with moderate disease who fail other therapies or patients with severe disease may require intravenous corticosteroids,"
        },
        {
            "id": "Surgery_Schwartz_8445",
            "title": "Surgery_Schwartz",
            "content": "dys-regulation. An autoimmune mechanism has also been postulated. Although there is no clear evidence linking an immunologic disorder to inflammatory bowel disease, the similarity of many of the extraintestinal manifestations to rheumatologic disorders has made this theory attractive. In summary, IBD is primarily characterized by intestinal inflammation, and medical therapy is focused on reducing or preventing that inflammation.45-49Pathology and Differential Diagnosis. Although ulcer-ative colitis and Crohn\u2019s colitis share many pathologic and clinical similarities, these conditions can be differentiated in 85% of patients. Ulcerative colitis is a mucosal process in which the colonic mucosa and submucosa are infiltrated with inflammatory cells. The mucosa may be atrophic, and crypt abscesses are common. Endoscopically, the mucosa is fre-quently friable and may possess multiple inflammatory pseu-dopolyps. In long-standing ulcerative colitis, the colon may be foreshortened and the"
        },
        {
            "id": "Surgery_Schwartz_8483",
            "title": "Surgery_Schwartz",
            "content": "colitis. Annual surveillance colonoscopy with multiple biopsies is recommended for patients with long-standing Crohn\u2019s colitis (>7 years in duration). As in ulcerative colitis, dysplasia is an indication for total proctocolectomy. Ileal pouch\u2013anal reconstruction is not recommended in these patients because of the risk for development of Crohn\u2019s disease within the pouch and the high risk of complications, such as fistula, abscess, stricture, pouch dysfunction, and pouch failure.Anal and Perianal Crohn\u2019s Disease. Anal and perianal mani-festations of Crohn\u2019s disease are very common and occur in 35% of all patients with Crohn\u2019s disease. Isolated anal Crohn\u2019s disease is uncommon, affecting only 3% to 4% of patients. Detection of anal Crohn\u2019s disease, therefore, should prompt evaluation of the remainder of the gastrointestinal tract.The most common perianal lesions in Crohn\u2019s disease are skin tags that are minimally symptomatic. Fissures are also common. Typically, a fissure from Crohn\u2019s"
        },
        {
            "id": "Surgery_Schwartz_8152",
            "title": "Surgery_Schwartz",
            "content": "involvement, with 30% having terminal ileitis exclusively. Recent studies suggest a prevalence of about 241 cases per 100,000 in the United States.36 The rates of Crohn\u2019s and ulcerative colitis have been increasing globally over the past several decades with substantial regional variations in inci-dence. The highest incidences are reported in western nations and those in northern latitudes, with Canada having the highest reported rates.37 In countries such as China, the prevalence of Crohn\u2019s disease is substantially below that seen in the West, but rates have been rapidly increasing recently.38 The incidence of Crohn\u2019s disease varies among ethnic groups within the same geographic region. For example, members of Eastern European Ashkenazi Jewish population are at a twoto fourfold higher risk of developing Crohn\u2019s disease than members of other popu-lations living in the same location.Most studies suggest that Crohn\u2019s disease is slightly more prevalent in females than in males. The mean"
        },
        {
            "id": "InternalMed_Harrison_22851",
            "title": "InternalMed_Harrison",
            "content": "The genetic factors defined to date that are recognized to mediate risk for IBD have highlighted the importance of several common mechanisms of disease (Table 351-3). These include the following: those genes that are associated with fundamental cell biologic Abbreviations: CD, Crohn\u2019s disease; IBD, inflammatory bowel disease; IL, interleukin; UC, ulcerative colitis."
        },
        {
            "id": "Surgery_Schwartz_8449",
            "title": "Surgery_Schwartz",
            "content": "Physical findings are also related to the site and severity of disease.In 15% of patients with colitis from inflammatory bowel disease, differentiation of ulcerative colitis from Crohn\u2019s colitis is impossible either grossly or microscopically (indeterminate colitis).50 These patients typically present with symptoms similar to ulcerative colitis. Endoscopic and pathologic findings usually include features common to both diseases. Increasingly, sero-logic markers have been employed to differentiate ulcerative colitis from Crohn\u2019s disease. The anti-Saccharomyces cerevi-siae antibody (ASCA) and perinuclear anticytoplasmic antibody (pANCA) may be useful in differentiating these two processes but require prospective study.50 Further differential diagnoses include infectious colitides, especially cytomegalovirus (CMV), Campylobacter jejuni, Entamoeba histolytica, toxigenic E Coli, C difficile, Neisseria gonorrhoeae, Salmonella, and Shigella species.Brunicardi_Ch29_p1259-p1330.indd"
        },
        {
            "id": "Surgery_Schwartz_8157",
            "title": "Surgery_Schwartz",
            "content": "to be defined. For example, the presence of a locus on chromosome 16 (the so-called IBD1 locus) has been linked to Crohn\u2019s disease. The IBD1 locus has been identified as the NOD2 gene. Persons with allelic variants on both chromosomes have a 40-fold relative risk of Crohn\u2019s disease com-pared to those without variant NOD2 genes. The relevance of this gene to the pathogenesis of Crohn\u2019s disease is biologically plau-sible, as the protein product of the NOD2 gene mediates the innate immune response to microbial pathogens. Other putative IBD loci have been identified on other chromosomes (IBD2 on chromose 12q, and IBD3 on chromose 6), and are under investigation.Although appendectomy has been shown to lower the risk of subsequent development of ulcerative colitis, it was suspected that the surgery may increase the risk of developing Crohn\u2019s disease. A meta-analysis has, however, suggested that the observed increased risk of Crohn\u2019s disease in the first few years after an appendectomy may"
        },
        {
            "id": "Pathology_Robbins_3529",
            "title": "Pathology_Robbins",
            "content": "that typically involve more than one segment, such as Crohn disease, are considered with the most frequently involved region. We begin our discussion with diseases of the oral cavity, since that is where the journey of food begins."
        },
        {
            "id": "Surgery_Schwartz_8172",
            "title": "Surgery_Schwartz",
            "content": "Crohn\u2019s disease is an acute abdomen related to small bowel obstruction, intra-abdominal abscess, or free intestinal perforation. In other patients, perianal abscesses and fistulas requiring surgical therapy may be the first manifestation of Crohn\u2019s disease.TherapyBecause no curative therapies are available for Crohn\u2019s dis-ease, the goal of treatment is to palliate symptoms rather than to achieve cure. Medical therapy is used to induce and maintain disease remission. Surgery is reserved for specific indications described later in this chapter. In addition, nutritional support in the form of aggressive enteral regimens or, if necessary, paren-teral nutrition, is used to manage the malnutrition that is com-mon in patients with Crohn\u2019s disease.Medical Therapy. Pharmacologic agents used to treat Crohn\u2019s disease include antibiotics, aminosalicylates, corticosteroids, immunomodulators, and biologic therapies. Antibiotics have an adjunctive role in the treatment of infectious complications"
        }
    ],
    "scores": [
        0.03863154172560113,
        0.025671863435826947,
        0.023523247673449002,
        0.022864414465706577,
        0.02201737656283111,
        0.020123260383000642,
        0.01879016524859475,
        0.018404390037990714,
        0.018187830687830687,
        0.017483795622286084,
        0.01709773237701949,
        0.016914654688377315,
        0.016892373485388454,
        0.016464237516869096,
        0.01627737709256931,
        0.01625538582060321,
        0.01613008130081301,
        0.01604380212644044,
        0.015852130325814534,
        0.015811730097444382,
        0.015480763717676739,
        0.015303765303765305,
        0.015247283211355067,
        0.015141165755919854,
        0.0151117700729927,
        0.015025877900829206,
        0.014770567472169427,
        0.014401036475981663,
        0.013765581562191731,
        0.013367084110489386,
        0.013247282608695652,
        0.013212977498691783
    ]
}